MediPal Holdings Corporation (MAHLY)
USD 16.08
(0.0%)
USD 16.08
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 47.33 Billion JPY | -3.35% |
| 2023 | 48.97 Billion JPY | 7.34% |
| 2022 | 45.62 Billion JPY | 18.27% |
| 2021 | 38.57 Billion JPY | -27.36% |
| 2020 | 53.11 Billion JPY | 7.36% |
| 2019 | 49.46 Billion JPY | 11.77% |
| 2018 | 44.26 Billion JPY | 12.74% |
| 2017 | 39.26 Billion JPY | -6.8% |
| 2016 | 42.12 Billion JPY | 28.45% |
| 2015 | 32.79 Billion JPY | -5.39% |
| 2014 | 34.66 Billion JPY | 21.54% |
| 2013 | 28.51 Billion JPY | 36.52% |
| 2012 | 20.89 Billion JPY | 54.19% |
| 2011 | 13.54 Billion JPY | -26.5% |
| 2010 | 18.43 Billion JPY | 37.0% |
| 2009 | 13.45 Billion JPY | -51.86% |
| 2008 | 27.95 Billion JPY | 0.63% |
| 2007 | 27.77 Billion JPY | 34.78% |
| 2006 | 20.6 Billion JPY | 87.58% |
| 2005 | 10.98 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 47.33 Billion JPY | -3.35% |
| 2024 Q2 | 10.22 Billion JPY | -17.58% |
| 2024 Q3 | 18.79 Billion JPY | 83.9% |
| 2024 Q1 | 12.4 Billion JPY | 8.4% |
| 2024 Q4 | 10.11 Billion JPY | -46.19% |
| 2023 Q2 | 12.02 Billion JPY | -11.02% |
| 2023 Q4 | 11.44 Billion JPY | -19.21% |
| 2023 FY | 48.97 Billion JPY | 7.34% |
| 2023 Q3 | 14.16 Billion JPY | 17.74% |
| 2023 Q1 | 13.51 Billion JPY | 57.3% |
| 2022 Q3 | 12.75 Billion JPY | 15.98% |
| 2022 FY | 45.62 Billion JPY | 18.27% |
| 2022 Q1 | 13.28 Billion JPY | 45.52% |
| 2022 Q2 | 10.99 Billion JPY | -17.22% |
| 2022 Q4 | 8.59 Billion JPY | -32.62% |
| 2021 Q4 | 9.12 Billion JPY | -20.25% |
| 2021 Q2 | 7.47 Billion JPY | -29.04% |
| 2021 Q1 | 10.53 Billion JPY | 2.67% |
| 2021 FY | 38.57 Billion JPY | -27.36% |
| 2021 Q3 | 11.44 Billion JPY | 53.19% |
| 2020 Q2 | 15.76 Billion JPY | 29.32% |
| 2020 Q4 | 10.25 Billion JPY | -31.2% |
| 2020 FY | 53.11 Billion JPY | 7.36% |
| 2020 Q1 | 12.18 Billion JPY | 27.75% |
| 2020 Q3 | 14.9 Billion JPY | -5.42% |
| 2019 FY | 49.46 Billion JPY | 11.77% |
| 2019 Q4 | 9.54 Billion JPY | -44.46% |
| 2019 Q3 | 17.17 Billion JPY | 48.89% |
| 2019 Q2 | 11.53 Billion JPY | -0.3% |
| 2019 Q1 | 11.57 Billion JPY | 14.98% |
| 2018 Q3 | 14.53 Billion JPY | 32.16% |
| 2018 Q2 | 10.99 Billion JPY | 26.99% |
| 2018 Q1 | 8.66 Billion JPY | 28.27% |
| 2018 FY | 44.26 Billion JPY | 12.74% |
| 2018 Q4 | 10.06 Billion JPY | -30.76% |
| 2017 Q3 | 12.06 Billion JPY | 31.14% |
| 2017 FY | 39.26 Billion JPY | -6.8% |
| 2017 Q1 | 11.63 Billion JPY | 12.3% |
| 2017 Q4 | 6.75 Billion JPY | -44.02% |
| 2017 Q2 | 9.19 Billion JPY | -20.97% |
| 2016 FY | 42.12 Billion JPY | 28.45% |
| 2016 Q4 | 10.36 Billion JPY | -23.12% |
| 2016 Q1 | 8.1 Billion JPY | -9.54% |
| 2016 Q2 | 10.33 Billion JPY | 27.61% |
| 2016 Q3 | 13.47 Billion JPY | 30.37% |
| 2015 Q3 | 9.29 Billion JPY | 22.75% |
| 2015 Q2 | 7.57 Billion JPY | 8.5% |
| 2015 Q4 | 8.95 Billion JPY | -3.62% |
| 2015 FY | 32.79 Billion JPY | -5.39% |
| 2015 Q1 | 6.97 Billion JPY | -20.03% |
| 2014 Q1 | 6.88 Billion JPY | 78.92% |
| 2014 FY | 34.66 Billion JPY | 21.54% |
| 2014 Q2 | 9.01 Billion JPY | 30.97% |
| 2014 Q4 | 8.72 Billion JPY | -13.09% |
| 2014 Q3 | 10.03 Billion JPY | 11.36% |
| 2013 Q4 | 3.84 Billion JPY | -57.7% |
| 2013 Q2 | 7.29 Billion JPY | -11.92% |
| 2013 Q1 | 8.28 Billion JPY | 11.41% |
| 2013 Q3 | 9.09 Billion JPY | 24.67% |
| 2013 FY | 28.51 Billion JPY | 36.52% |
| 2012 Q1 | 2.18 Billion JPY | 246.12% |
| 2012 Q2 | 5.66 Billion JPY | 158.92% |
| 2012 FY | 20.89 Billion JPY | 54.19% |
| 2012 Q4 | 7.43 Billion JPY | 32.51% |
| 2012 Q3 | 5.61 Billion JPY | -0.88% |
| 2011 Q3 | -641 Million JPY | -108.67% |
| 2011 FY | 13.54 Billion JPY | -26.5% |
| 2011 Q4 | -1.49 Billion JPY | -133.39% |
| 2011 Q1 | 8.29 Billion JPY | 215.84% |
| 2011 Q2 | 7.39 Billion JPY | -10.89% |
| 2010 Q1 | 2.44 Billion JPY | 524.83% |
| 2010 Q2 | 6.79 Billion JPY | 177.85% |
| 2010 Q3 | 6.55 Billion JPY | -3.65% |
| 2010 Q4 | 2.62 Billion JPY | -59.91% |
| 2010 FY | 18.43 Billion JPY | 37.0% |
| 2009 FY | 13.45 Billion JPY | -51.86% |
| 2009 Q4 | -576 Million JPY | -117.27% |
| 2009 Q3 | 3.33 Billion JPY | 15.55% |
| 2009 Q2 | 2.88 Billion JPY | 0.0% |
| 2008 FY | 27.95 Billion JPY | 0.63% |
| 2007 FY | 27.77 Billion JPY | 34.78% |
| 2006 FY | 20.6 Billion JPY | 87.58% |
| 2005 FY | 10.98 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| China Medicine Corporation | 12.26 Million USD | -385762.361% |
| DH Enchantment Inc. | -145.23 Thousand USD | 32588454.368% |
| Exlites Holdings International, Inc. | -15.49 Thousand USD | 305558524.79% |
| Itonis, Inc. | -38.31 Thousand USD | 123547476.664% |
| One Step Vending Corp. | -27.79 Thousand USD | 170316760.669% |
| MediPal Holdings Corporation | 312.71 Million USD | -15035.462% |
| PD-Rx Pharmaceuticals, Inc. | -190.47 Thousand USD | 24848769.393% |
| Pharmagen, Inc. | -2159.03 USD | 2192234575.667% |
| Suzuken Co., Ltd. | 230.42 Million USD | -20440.675% |